BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 27, 2003
View Archived Issues
Promising results for ferumoxytol in anemia and chronic kidney disease
Read More
SBIR grant for PTC Therapeutics' novel antibiotics research
Read More
Positive trends in improvement of FEV1 in phase II trial of DCF-987
Read More
Peplin Biotech acquires portfolio of polyunsaturated fatty acid compounds
Read More
Low systemic toxicity reported for NLCQ-1 in rats
Read More
MLN-2704 potentially effective against bone metastases in prostate cancer
Read More
Preliminary results for motexafin gadolinium combined with doxorubicin in solid tumors
Read More
Good safety profile found for LE-SN-38 in advanced cancer patients
Read More
Assessment of two treatment schedules for OSI-7836 in cancer patients
Read More
Cetuximab enhances antitumor effects of cisplatin in late-stage clinical trial
Read More
Promising results reported for DX-8951f in pediatric cancer
Read More
CCI-779 in brain and pediatric tumors
Read More
Antitumor effects of lonafarnib unrelated to Ras mutations or the PI3/Akt pathway
Read More
Japanese researchers describe protein kinase inhibitors as antineoplastic enhancing agents
Read More
Diamyd increases levels of C-peptide in diabetes patients
Read More
New GSK-3 inhibitors and their use covered by AstraZeneca patent
Read More
Trigen identifies new antithrombotic compounds
Read More
Yissum presents multifunctional agents for asthma and other respiratory diseases
Read More
GSK scientists describe novel p38 kinase inhibitors in a recent patent
Read More
Novel EGFR inhibitors under study at Boehringer Ingelheim
Read More
Potassium Kv1.5 channel blockers reported by BMS and ICAgen researchers
Read More
Sanofi-Synthelabo claims novel GlyT inhibitors
Read More
Allergan submits NDA for oral tazarotene for psoriasis
Read More
Final pivotal study of exenatide reports positive results
Read More
PROTERM trial evaluates Prochieve for prevention of preterm delivery
Read More
Phase III program commences for PTI-901 in IBS
Read More
Metvix approved in Switzerland
Read More
Pilot study of SWT-01.100 supports mode of action for treatment of psoriasis
Read More
Vasogen chooses brand name for immune modulation therapy
Read More